However, within the tumor microenvironment, they suppress anti-tumor responses.[29] Furthermore, the infiltration rate of CD8 + effector T cells has prognostic value for the survival of patients with BC and is independent of traditional clinical factors, such as tumor grading and lymph node staging.[30]. The gene discussed is CD8A; the disease is neoplasm.